NYSCF Principal Scientist Josephine (Josi) Wesely, PhD, was probably the only kid who showed up to her doctor’s appointments with scientific papers in hand. “I was...
Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai partner to advance medical research at life sciences hub New York, NY & Troy,...
The Context: Gene therapies hold a great deal of promise for treating a wide range of diseases. For the gene therapy to be effective, however, proteins...
The Context: Our bones keep specialized pools of stem cells on hand to aid in general upkeep and injury repair throughout our lives, but this process...
In 1995, Timothy Ray Brown received bad news: he tested positive for HIV. The AIDS epidemic was in full swing. He recalled to New York Magazine...
In honor of Women’s History Month, NYSCF hosted a fireside conversation between equity advocates Maike Sander, MD (Max-Delbrück Center, Berlin, Germany) and Raeka Aiyar, PhD (NYSCF)...
People over the age of 75 have nearly a 30% risk of developing age-related macular degeneration (AMD), which now affects 11 million in the United States....
The Context: Immunotherapies for cancer hold a lot of promise by training immune cells called T cells to recognize and attack cancerous cells. T cells can...
STEM-PD, a investigational cell therapy developed by NYSCF – Robertson Stem Cell Investigator Alumna Malin Parmar, PhD, of Lund University, reached its first patient last month...
Gene editing: you’ve likely heard of it before, but what is the science behind biomedicine’s most versatile new star? How is it used for research and...
The International Society for Stem Cell Research (ISSCR) announced this month that NYSCF – Robertson Stem Cell Investigator Alumnus Takanori Takebe, MD, PhD, of Cincinnati Children’s...
Scientific progress is dependent on many factors, and one critical component is public engagement. The public relies on biomedical research to advance solutions for pressing health...
The Context: INAD is a rare neurological disease affecting children, often referred to as a “pediatric Parkinson’s,” which is typically diagnosed between six months to three...
The Context: ALS is a disease that manifests differently in each patient, with some cases resulting from genetic predispositions, and others sporadically. Because the causes can...
The Context: All our blood cells are created in the bone marrow by blood-forming stem cells, and when this process goes awry, leukemia can arise. Scientists...
The Context: Turning patient stem cells into the different cell types of the brain offers immense promise for studying and treating neurodegenerative diseases such as Alzheimer’s,...
What goes into successful disease research? Scientists, of course, who design and conduct experiments. Patients, who generously offer to donate their cells or participate in clinical...
Earlier this month, NYSCF hosted an intimate conversation with Interim CEO Derrick Rossi, PhD, who shared the journey of his already long and storied career in...
“I moved to New York in 2006, exactly when [Shinya] Yamanaka made the groundbreaking discovery of induced pluripotent stem cells, which was completely revolutionizing the way...
As NYSCF enters 2023, we’re taking a moment to look back at the defining moments of 2022. Whether it was gathering in person again for our...
We hear a lot about the importance of promoting diversity and creating inclusive cultures in the workplace, but why does it matter for science? Why should...
The Context: As we listen to the world around us, our brains can tell us when something doesn’t sound right – i.e. the wrong music note,...
The Context: When someone builds up excess fat around their liver, they can develop a condition called non-alcoholic fatty liver disease (NAFLD). Those with type 2...
The Context: We don’t need to tell you that the world is a stressful place – and everyone will have to overcome extreme challenges at some...
